Pediatrics Group Issues New Guidelines for Talking to Teens About Marijuana
The American Academy of Pediatrics has issued new guidelines for doctors and parents to talk to teens about the risks of using marijuana, CNN reports.
A bill introduced Tuesday by three U.S. senators would end the federal prohibition on medical marijuana, The Washington Post reports.
The bill was introduced by Cory Booker of New Jersey and Kirsten Gillibrand of New York, both Democrats, and Rand Paul of Kentucky, a Republican.
The Compassionate Access, Research Expansion and Respect States (CARERS) Act, would reclassify marijuana from Schedule I to Schedule II under the Controlled Substances Act. Schedule I drugs, which include heroin, have no accepted medical use in the United States. Schedule II drugs have a legitimate medical use but also have a high potential for abuse.
The bill would permit Veterans Affairs doctors to prescribe medical marijuana to veterans, and would make it easier for scientists to obtain marijuana for medical research. It would allow banks and credit unions to provide the same services to the marijuana industry as they do to other businesses, without the fear of federal prosecution or investigation, the article notes.
Because marijuana is still illegal under federal law, banks have been reluctant to conduct business with marijuana-related companies. Banks have feared being accused of helping these businesses launder their money.
The measure would not legalize medical marijuana in all 50 states, but would prevent federal law enforcement from prosecuting patients, doctors and caregivers in states that have their own medical marijuana programs. Currently 23 states plus the District of Columbia have legalized medical marijuana.
An additional 12 states have approved use of marijuana strains with high levels of cannabidiol (CBD), which does not produce the high associated with the drug, and is used to treat epileptic seizures. The measure would remove specific strains of CBD oil from the federal definition of marijuana, to allow its use in treatment of intractable seizures.
The bill’s fate in the Senate is unclear, according to the newspaper.